BHOPAL: The future and functioning about sole super-speciality hospital for treatment of Bhopal gas victims- Bhopal memorial hospital and research centre (BMHRC) will be deliberated upon at a meeting of Supreme Court appointed 17-member expert committee here on Thursday.

The committee headed by Lt Gen (Retd) Dr D Raghunath, principal executive (Retd.) Sir Dorabji Tata Centre for Research in Tropical Diseases has been constituted by the apex court to look into the functioning of BMHRC and recommend to improve its efficiency as a super speciality medical centre.

Dengue poses a substantial economic and disease burden in Southeast Asia (SEA). Quantifying this burden is critical to set policy priorities and disease-control strategies.

Kyasanur forest disease (KFD), a tick-borne viral disease with hemorrhagic manifestations, is localised in five districts of Karnataka state, India. Annual rounds of vaccination using formalin inactivated tissue-culture vaccine have been conducted in the region since 1990. Two doses of vaccine are administered to individuals aged 7–65 years at an interval of one month followed by periodic boosters after 6–9 months. In spite of high effectiveness of the vaccine reported in earlier studies, KFD cases among vaccinated individuals have been recently reported.

Dengue fever is now the fastest spreading insect-borne virus in the world and has reached “epidemic potential,” the World Health Organization says.

With over a hundred million annual infections and rising morbidity and mortality, Plasmodium vivax malaria remains largely a neglected disease. In particular, the dependence of this malaria species on relapses and the potential significance of the dormant stage as a therapeutic target, are poorly understood.

WHO reports unprecedented progress against 17 neglected tropical diseases, thanks to a new global strategy, a regular supply of quality assured, cost-effective medicines and support from global partners.

An accurate early warning system to predict impending epidemics enhances the effectiveness of preventive measures against dengue fever. The aim of this study was to develop and validate a forecasting model that could predict dengue cases and provide timely early warning in Singapore.

Open source drug discovery offers potential for developing new and inexpensive drugs to combat diseases that disproportionally affect the poor. The concept borrows two principle aspects from open source computing (i.e., collaboration and open access) and applies them to pharmaceutical innovation. By opening a project to external contributors, its research capacity may increase significantly. To date there are only a handful of open source R&D projects focusing on neglected diseases.

Dengue virus belongs to family Flaviviridae, having four serotypes that spread by the bite of infected Aedes mosquitoes. It causes a wide spectrum of illness from mild asymptomatic illness to severe fatal dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Approximately 2.5 billion people live in dengue-risk regions with about 100 million new cases each year worldwide. The cumulative dengue diseases burden has attained an unprecedented proportion in recent times with sharp increase in the size of human population at risk.

WHO panel proposed treaty requires all governments to share cost

India supports a proposed legally binding global instrument that requires all governments to share the cost of research and development (R&D). The treaty, recommended by a World Health Organisation panel, will boost access to countries least able to pay for medical innovations but need it most. This would also delink profits from medical discoveries.